An interventional study of Virtual Reality Avatar Therapy (VRAT) and Assertiveness Training Program (ATP) in Psychosis, Schizophrenia and Schizo Affective Disorder, sponsored by Psychiatric University Hospital, Zurich. Recruiting at 1 site in Switzerland. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-09-28.
Sponsored by Psychiatric University Hospital, Zurich · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 25 studies in Psychotic Disorders with a site in Switzerland — 10 open to participants now, 11 under way, 3 of them phase 3. Psychotic Disorders · Switzerland.
Among the 25 studies in Psychotic Disorders with a site in Switzerland, this one is the 10th largest by planned enrollment of the 20 interventional ones that give a count, is one of 4 that started in 2021, is one of 13 with no phase, reaches primary completion later than 1 of the 10 other live ones, and was the 10th registered.
1,593 studies on the registry are indexed under Psychotic Disorders; 283 are open to participants now.
Browse Psychotic Disorders studies →10 of the 25 studies in Psychotic Disorders with a site in Switzerland are open now. Recruiting first, the newest first:
University of Oxford · Sites in Switzerland, Austria, Germany and 6 more countries
Ages 16–40
Philipp Homan · Sites in Switzerland, Czechia, Ireland and 3 more countries
Ages 18–65 · Healthy volunteers
Marco Armando · Sites in Switzerland
Ages 14–30
Tobias Melcher · Sites in Switzerland
Ages 55+
Indrit Begue · Sites in Switzerland
Ages 18–65
A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →
Of the 204 Psychotic Disorders studies recruiting now, 53 (26%) set no upper age limit and 142 (70%) stop at 75 or younger; 50 take children under 18; 41 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
25 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 4 started in 2021.
This study's planned enrollment of 100 is above the median of 65 across 1,326 interventional studies indexed under Psychotic Disorders.
Median enrollment 100 across the 20 interventional studies, 156 across the 5 observational. Of the 9 that completed or were terminated, 1 (11%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 25 have an industry lead sponsor. The 10 most frequent:
Psychiatric University Hospital, Zurich is the lead sponsor of 22 studies on the registry; 7 are open to participants now.
Psychiatric University Hospital, Zurich has 3 studies filed under Psychotic Disorders — fewer than ten, so there is no comparison to draw.
3 of the studies in Psychotic Disorders with a site in Switzerland that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05905003Brigham and Women's HospitalAMP SCZ® Observational Study: PREDICT-DPACC | 2027-04-30 |
| NCT07060742Tobias MelcherStudy on the Use of Exergames to Support Older Adults With Psychosis | 2027-05-15 |
| NCT05911529Psychiatric University Hospital, ZurichTracking the Linguistic Signatures of Motivational Interviewing in Acute Psychosis | 2027-10-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 25 studies in Psychotic Disorders with a site in Switzerland, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Hearing voices is probably the worst form of acoustic hallucinations; which can be experienced as severely disturbing and is influenced by diverse factors including the ability of the individual to influence and control the hallucinatory experience itself. In recent years virtual reality has become a treatment option. In the so-called AVATAR Therapy, patients with schizophrenia and acoustic hallucinations design a visual and auditory recreation (avatar) of the entity to which they attribute their hallucinations. Working with a therapist over the course of several sessions, participants change the avatar from controlling to benevolent. Avatar Therapy involves similar processes to learning and cognitive restructuring, comparable to other psychotherapeutic interventions. The investigators plan to conduct an interventional study using a cross-over design, to compare the feasibility and efficacy of virtual reality avatar therapy for patients with acoustic hallucinations (independent of psychiatric diagnosis) with a cognitive behavioural group therapy aimed to improve social competence.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
In the VRAT, patients with schizophrenia and acoustic hallucinations design a visual and auditory recreation (avatar) of the entity to which they attribute their hallucinations. Working with a therapist over the course of several sessions, participants change the avatar from controlling to benevolent.
Behavioral: Virtual Reality Avatar Therapy (VRAT) · Behavioral: Assertiveness Training Program (ATP)
The ATP is a transdiagnostic cognitive behavioural treatment programme, which aims to increase self-confidence and social competence in patients with a psychiatric disorder.
Behavioral: Virtual Reality Avatar Therapy (VRAT) · Behavioral: Assertiveness Training Program (ATP)
The Virtual Reality Avatar Therapy (VRAT) is a Cognitive Behavioral Intervention, delivered through Virtual Reality.
The Assertiveness Training Program (ATP) is a Cognitive Behavioral Intervention, delivered as group therapy.
Psychopathological Assessment
Symptom Questionnaire
Time frame: Change: Baseline, 3, 6 weeks, 6 and 12 months]
Psychotic Symptoms
Symptom Questionnaire
Time frame: Change: Baseline, 3, 6 weeks, 6 and 12 months]
Insecurity- Self-confidence
Symptom Questionnaire
Time frame: Change: Baseline, 3, 6 weeks, 6 and 12 months]
Plan to share: No
Started Jul 2021 (actual). Primary completion is estimated for May 2025, 46 months after the start.
Of 460 non-industry interventional studies with no phase under Psychotic Disorders, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 52. This study's planned 46 months is above that.
Counting every sponsor, half of 462 studies reached it within 34 months; a quarter within 19 and three quarters within 52.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Psychiatric University Hospital, Zurich